• Skip to primary navigation
  • Skip to content
  • Skip to footer
Alzheimer's Clinical Trials Consortium

Alzheimer's Clinical Trials Consortium

  • Submit a Proposal
  • About Us
    • Committees
    • Units
  • Projects
  • Sites
  • News
  • Alzheimer’s Information
  • Contact Us

IMPACT-AD is now accepting applications!

We are excited to announce that The Institute on Methods and Protocols for Advancement in Clinical Trials in ADRD (IMPACT-AD) is now accepting applications for its 2023 cycle. IMPACT-AD is an exciting opportunity for interested researchers to receive comprehensive training in clinical trials for Alzheimer’s Disease and Related Dementias (ADRD).  Two unique in-person tracks will be offered as part of IMPACT-AD 2023. Tracks will commence simultaneously and overlap. Applicants are permitted to apply to only one track per application cycle.
  • Professionals Track – This track seeks applications from individuals with at least 2 years of experience in AD/ADRD research and/or clinical trials (in a broad variety of roles including, but not limited to clinicians, study coordinators, statisticians, psychometricians, and other study professionals) who wish to further their knowledge and advance their careers in AD/ADRD clinical trials (3.5 days).
  • Fellowship Track – This track seeks applications from individuals seeking to serve as Principal Investigators in AD/ADRD trials now or in the future and offers mentored training in protocol development. Applications are open to individuals in their fellowship or postdoctoral training, faculty members or equivalent positions (5.5 days)
Trainee selection will be competitive; IMPACT-AD will cover all travel costs to attend this meeting. The course will take place at the Estancia Hotel in San Diego, CA, from August 27- September 1, 2023. For more information on the course, please see the attached course Request For Applications. Application instructions and additional information can be found at http://impact-ad.org/. A stated goal of the IMPACT-AD Course is to diversify the nation’s ADRD trialists. As such, we seek applicants from a broad range of geographic, demographic, and professional backgrounds. So, please forward this email to any person or organization that you believe may benefit from this course. We greatly appreciate your help in reaching a broad and diverse audience.

Footer

Alzheimer's Clinical Trials Consortium
Alzheimer's Clinical Trials Consortium

ACTC is funded by a Cooperative Agreement from the National Institute on Aging, National Institutes of Health.  Cooperative Agreement number U24AG057437.

  • Submit a Proposal
  • About Us
  • Projects
  • Sites
  • Job Opportunities
  • News
  • Alzheimer’s Information
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • California Privacy Rights
ACTC Member ResourcesSubmit A Proposal

Copyright © USC ATRI 2023. All Rights Reserved.